Clinical Trial Update: Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2

View source ↗

Summary

This update reports clinical outcomes for pacemaker patients in the OPTI-MIND 2 trial, examining outcomes by pacing modality and primary indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradyarrhythmia

Drugs mentioned

• Cardiac pacemaker (pacemaker)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Bradyarrhythmia | Status: COMPLETED